Global PD-1 And PD-L1 Inhibitors Market Report By Type (PD-1,PD-L1), By Application (Head and neck cancers,Hodgkin lymphoma,Kidney cancer,Melanoma of the skin,Non-small cell lung cancer) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global PD-1 And PD-L1 Inhibitors Market Report
Brand: Value Market Research
SKU: Biotechnology
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11213687

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for PD-1 And PD-L1 Inhibitors Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022-2028.

PD-1 inhibitors and PD-L1 inhibitors refer to a group of checkpoint inhibitor anticancer drugs. It blocks the action of PD-1 and PDL1 immune checkpoint proteins there on the surface of cells. Immune checkpoint inhibitors are emerging as a cutting edge treatment for numerous types of cancer. The immune checkpoints are responsible for reducing antitumor immune responses. Some examples include atezolizumab, avelumab, Bavencio, cemiplimab, durvalumab, Imfinzi, and others. PD-1 binds to PD-L1 and tells the T cell or immune cells to leave the other cell alone. In the cancer disease state, the PD-L1 on the tumor cells interaction with PD-1 on a T-cell minimizes T-cell function signals to avert the immune system from attacking the tumor cells.

Market Dynamics

The rising prevalence rate of various types of cancer worldwide is the primary factor driving the PD-1 and PD-l1 inhibitors market. The PD-1/PD-L1 Inhibitors promise improved survival of patients with low toxicity is a considerable market driving factor, contributing to the pd-1 and pd-l1 inhibitors market's growth. Also, the rapid rise in FDA approval of PD-L1 inhibitors is positively impacting the growth of the pd-1 and pd-L1 inhibitors market. A rise in investments in the PD-1 and PD-L1 inhibitors market for finding better immuno-oncology therapies for colon cancer, renal cell cancer, non-small cell lung cancer (NSCLC), and melanoma, is expected to offer profitable growth opportunities for key players of the Pd-1 and PD-L1 inhibitors market in the coming years

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each segment in the global market of pd-1 and pd-l1 inhibitors.

Market Segmentation

The report segments the pd-1 and pd-l1 inhibitors market and analyses it with respect to the geography, intending to keep the marketer informed and help them identify the target demographics for the product or service.

By Type

PD-1
PD-L1

By Application

Head and neck cancers
Hodgkin lymphoma
Kidney cancer
Melanoma of the skin
Non-small cell lung cancer

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for pd-1 and pd-l1 inhibitors market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global PD-1 And PD-L1 Inhibitors Market by Revenue (USD MN)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the pd-1 and pd-l1 inhibitors market include Bristol-Myers Squibb, Merck & Co., F. Hoffmann-La Roche AG, Sanofi, Amgen, Gilead Sciences, AstraZeneca, Novartis, Pfizer, Celgene.S. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of PD-1 and PD-L1 Inhibitors Market
       2.2. Global PD-1 and PD-L1 Inhibitors Market Snapshot

3 . PD-1 AND PD-L1 INHIBITORS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of PD-1 and PD-L1 Inhibitors Market
       3.3. Market Restraints of PD-1 and PD-L1 Inhibitors Market
       3.4. Opportunities of PD-1 and PD-L1 Inhibitors Market
       3.5. Trends of PD-1 and PD-L1 Inhibitors Market
       3.6. Porter’s Five Force Analysis of PD-1 and PD-L1 Inhibitors Market
       3.7. PD-1 and PD-L1 Inhibitors Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Type
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. PD-1 and PD-L1 Inhibitors Value Chain Analysis
       4.2. PD-1 and PD-L1 Inhibitors Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. PD-1 and PD-L1 Inhibitors Raw Material Manufactures List
           4.2.3. Price Trend of PD-1 and PD-L1 Inhibitors Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on PD-1 and PD-L1 Inhibitors Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. PD-1 and PD-L1 Inhibitors Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the PD-1 and PD-L1 Inhibitors Market
       5.5. COVID-19: Micro and Macro Factor Analysis on PD-1 and PD-L1 Inhibitors Market

6 . GLOBAL PD-1 AND PD-L1 INHIBITORS MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Historical Data 2016-2019
       6.3 Global PD-1 and PD-L1 Inhibitors Market Analysis by Type
       6.4 Market Analysis of PD-1 by Regions
       6.6 Market Analysis of PD-L1 by Regions

7 . GLOBAL PD-1 AND PD-L1 INHIBITORS MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Historical Data 2016-2019
       7.3 Global PD-1 and PD-L1 Inhibitors Market Analysis by Application
       7.4 Market Analysis of Head and Neck Cancers by Regions
       7.5 Market Analysis of Hodgkin Lymphoma by Regions
       7.6 Market Analysis of Kidney Cancer by Regions
       7.7 Market Analysis of Melanoma of the Skin by Regions
       7.8 Market Analysis of Non-Small Cell Lung Cancer by Regions

8 . GLOBAL PD-1 AND PD-L1 INHIBITORS MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview and Historic Data
           8.3.2. North America PD-1 and PD-L1 Inhibitors Market Estimate By Market Segment
           8.3.3. North America PD-1 and PD-L1 Inhibitors Market Estimate By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview and Historic Data
           8.4.2. Europe PD-1 and PD-L1 Inhibitors Market Estimate by Market Segment
           8.4.3. Europe PD-1 and PD-L1 Inhibitors Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview and Historic Data
           8.5.2. Asia Pacific PD-1 and PD-L1 Inhibitors Market Estimate by Market Segment
           8.5.3. Asia Pacific PD-1 and PD-L1 Inhibitors Market Estimate by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview and Historic Data
           8.6.2. Latin America PD-1 and PD-L1 Inhibitors Market Estimate by Market Segment
           8.6.3. Latin America PD-1 and PD-L1 Inhibitors Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview and Historic Data
           8.7.2. Middle East & Africa PD-1 and PD-L1 Inhibitors Market Estimate by Market Segment
           8.7.3. Middle East & Africa PD-1 and PD-L1 Inhibitors Market Estimate by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa

9 . COMPETITIVE LANDSCAPE OF THE PD-1 AND PD-L1 INHIBITORS COMPANIES
       9.1. PD-1 and PD-L1 Inhibitors Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments

10 . COMPANY PROFILES OF PD-1 AND PD-L1 INHIBITORS INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Bristol-Myers Squibb
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Merck & Co.
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. F. Hoffmann-La Roche AG
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Sanofi
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Amgen
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Gilead Sciences
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. AstraZeneca
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Novartis
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Pfizer
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Celgene
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of PD-1 and PD-L1 Inhibitors Report
Market Research Process
Market Research Methodology
Global PD-1 and PD-L1 Inhibitors Market Size, by Region
Porters Five Forces Analysis
Market Attractiveness Analysis by Type
Market Attractiveness Analysis by Application
Market Attractiveness Analysis by Region
Value Chain Analysis
Global PD-1 and PD-L1 Inhibitors Market Analysis by Type
Global PD-1 and PD-L1 Inhibitors Market Analysis in PD-1 by Region
Global PD-1 and PD-L1 Inhibitors Market Analysis in PD-L1 by Region
Global PD-1 and PD-L1 Inhibitors Market Analysis by Application
Global PD-1 and PD-L1 Inhibitors Market Analysis in Head and Neck Cancers by Region
Global PD-1 and PD-L1 Inhibitors Market Analysis in Hodgkin Lymphoma by Region
Global PD-1 and PD-L1 Inhibitors Market Analysis in Kidney Cancer by Region
Global PD-1 and PD-L1 Inhibitors Market Analysis in Melanoma of the Skin by Region
Global PD-1 and PD-L1 Inhibitors Market Analysis in Non-Small Cell Lung Cancer by Region
Global PD-1 and PD-L1 Inhibitors Market by Revenue
North America PD-1 and PD-L1 Inhibitors Market by Revenue
Europe PD-1 and PD-L1 Inhibitors Market by Revenue
Asia Pacific PD-1 and PD-L1 Inhibitors Market by Revenue
Latin America PD-1 and PD-L1 Inhibitors Market by Revenue
Middle East & Africa PD-1 and PD-L1 Inhibitors Market by Revenue
Recent Development in PD-1 and PD-L1 Inhibitors Industry
Company Market Share Analysis

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "